American Diabetes Association Includes “Disposable Patch-Like Device,” such as V-Go® from Valeritas, in the ADA Standards of Medical Care in Diabetes - 2019
28 mai 2019 07h00 HE
|
Valeritas, Inc.
BRIDGEWATER, N.J., May 28, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, today announced the...
Valeritas’ V-Go® Demonstrates Positive Impact in Diabetes Quality Performance Measures in an Older Adult Population
22 mai 2019 07h00 HE
|
Valeritas, Inc.
BRIDGEWATER, N.J., May 22, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, today announced...
Valeritas Announces Reverse Stock Split
17 mai 2019 07h00 HE
|
Valeritas, Inc.
BRIDGEWATER, N.J., May 17, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas Exhibits at Taking Control of Your Diabetes Conferences
13 mai 2019 07h00 HE
|
Valeritas, Inc.
BRIDGEWATER, N.J., May 13, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas Announces First Quarter 2019 Financial Results and Updates Full Year 2019 Revenue Guidance
09 mai 2019 16h05 HE
|
Valeritas, Inc.
BRIDGEWATER, N.J., May 09, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas Expects First Quarter Revenue of $6.4 million
02 mai 2019 07h00 HE
|
Valeritas, Inc.
BRIDGEWATER, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, announced today it...
Valeritas to Present at Upcoming Investor Conferences
29 avr. 2019 07h00 HE
|
Valeritas, Inc.
BRIDGEWATER, N.J., April 29, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates a Reduction in A1c Levels by 1.5 and Total Daily Insulin Dosage by 14%
26 avr. 2019 07h00 HE
|
Valeritas, Inc.
BRIDGEWATER, N.J., April 26, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, today announced...
Valeritas to Report First Quarter 2019 Financial Results on May 9, 2019
22 avr. 2019 07h00 HE
|
Valeritas, Inc.
BRIDGEWATER, New Jersey, April 22, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple,...
Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates 24% Reduction in Total Daily Insulin Dosage and Lower A1C Compared to Standard Insulin Treatment
08 avr. 2019 07h00 HE
|
Valeritas, Inc.
BRIDGEWATER, N.J., April 08, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, today announced the...